Inify Laboratories announced the addition of specialized medical competence to the company's management team and organization. Dr. Claes Lind
will join Inify Laboratories in September 2022 as Chief Medical Officer. He holds a M.D. as well as a Ph.D. in the field of prostate cancer pathology from Karolinska Institute, and has 14 years of experience in diagnostic pathology. He has worked as an expert pathologist in clinical diagnostics, cancer research, and higher education. Before joining Inify Laboratories, he acted as a senior consultant pathologist in Urological and Gynecological pathology at Karolinska University Hospital. He has collaborated in various translational research projects related to urological oncology. Dr. Lindh is also an experienced educator in pathology for both medical professionals and students.